FAM184A
geneOn this page
Also known as FLJ13942
Summary
FAM184A (family with sequence similarity 184 member A, HGNC:20991) is a protein-coding gene on chromosome 6q22.31, encoding Protein FAM184A (Q8NB25).
Located in several cellular components, including P-body; cytosol; and microtubule organizing center.
Source: NCBI Gene 79632 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 176 total
- MANE Select transcript:
NM_024581
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20991 |
| Approved symbol | FAM184A |
| Name | family with sequence similarity 184 member A |
| Location | 6q22.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ13942 |
| Ensembl gene | ENSG00000111879 |
| Ensembl biotype | protein_coding |
| Entrez | 79632 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000338891, ENST00000352896, ENST00000368472, ENST00000368475, ENST00000448815, ENST00000475529, ENST00000481884, ENST00000482219, ENST00000517987, ENST00000521043, ENST00000521531, ENST00000522284, ENST00000617072, ENST00000621231
RefSeq mRNA: 3 — MANE Select: NM_024581
NM_001100411, NM_001288576, NM_024581
CCDS: CCDS43499, CCDS43500, CCDS75508
Canonical transcript exons
ENST00000338891 — 18 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002094886 | 118966835 | 118966952 |
| ENSE00002106384 | 118964667 | 118964771 |
| ENSE00002112598 | 119078141 | 119078664 |
| ENSE00002115099 | 118961761 | 118961963 |
| ENSE00002119469 | 118974428 | 118974574 |
| ENSE00002137709 | 118959763 | 118960184 |
| ENSE00002138046 | 118975024 | 118975208 |
| ENSE00002225962 | 119022945 | 119023080 |
| ENSE00002251225 | 119011309 | 119011431 |
| ENSE00002255677 | 118979365 | 118979518 |
| ENSE00002279516 | 119002899 | 119003049 |
| ENSE00002285904 | 119016747 | 119016944 |
| ENSE00002298360 | 118975917 | 118976044 |
| ENSE00002308078 | 118980138 | 118980350 |
| ENSE00002308197 | 119019978 | 119020159 |
| ENSE00002321294 | 119003501 | 119003622 |
| ENSE00002323800 | 119006447 | 119006608 |
| ENSE00003529269 | 119023959 | 119024813 |
Expression profiles
Bgee: expression breadth ubiquitous, 229 present calls, max score 90.75.
FANTOM5 (CAGE): breadth broad, TPM avg 2.8797 / max 71.7681, expressed in 661 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 75311 | 1.6291 | 541 |
| 75314 | 0.5027 | 305 |
| 75313 | 0.4028 | 218 |
| 75312 | 0.3193 | 207 |
| 204178 | 0.0258 | 7 |
Top tissues by expression
279 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| caudate nucleus | UBERON:0001873 | 90.75 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.61 | gold quality |
| nucleus accumbens | UBERON:0001882 | 90.53 | gold quality |
| amygdala | UBERON:0001876 | 89.95 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 89.95 | gold quality |
| cingulate cortex | UBERON:0003027 | 89.85 | gold quality |
| putamen | UBERON:0001874 | 89.57 | gold quality |
| ventricular zone | UBERON:0003053 | 89.52 | gold quality |
| right frontal lobe | UBERON:0002810 | 89.46 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.17 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 89.17 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.17 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.06 | gold quality |
| pituitary gland | UBERON:0000007 | 88.91 | gold quality |
| right testis | UBERON:0004534 | 88.85 | gold quality |
| left testis | UBERON:0004533 | 88.81 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.76 | gold quality |
| cortical plate | UBERON:0005343 | 88.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.81 | gold quality |
| cerebellum | UBERON:0002037 | 87.52 | gold quality |
| testis | UBERON:0000473 | 87.36 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 87.31 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 87.20 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.88 | gold quality |
| telencephalon | UBERON:0001893 | 86.30 | gold quality |
| forebrain | UBERON:0001890 | 86.27 | gold quality |
| thyroid gland | UBERON:0002046 | 86.26 | gold quality |
| secondary oocyte | CL:0000655 | 85.78 | gold quality |
| brain | UBERON:0000955 | 85.75 | gold quality |
| neocortex | UBERON:0001950 | 85.72 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9388 | yes | 195.46 |
| E-CURD-119 | yes | 46.09 |
| E-ANND-3 | yes | 18.25 |
| E-MTAB-9543 | no | 1.22 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F1
miRNA regulators (miRDB)
44 targeting FAM184A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-329-3P | 99.91 | 66.56 | 1234 |
| HSA-MIR-362-3P | 99.91 | 66.38 | 1267 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam184aa | ENSDARG00000002635 |
| danio_rerio | fam184ab | ENSDARG00000014081 |
| mus_musculus | Fam184a | ENSMUSG00000019856 |
| rattus_norvegicus | Fam184a | ENSRNOG00000026407 |
Paralogs (1): FAM184B (ENSG00000047662)
Protein
Protein identifiers
Protein FAM184A — Q8NB25 (reviewed: Q8NB25)
All UniProt accessions (11): Q8NB25, A0A087X2A7, A0A0C4DGZ2, B9DI78, E7EQ67, H0Y672, H0YBA5, H0YBC0, H0YBE3, H0YBZ6, H7BY63
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. P-body. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite.
Similarity. Belongs to the FAM184 family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NB25-1 | 1 | yes |
| Q8NB25-2 | 2 | |
| Q8NB25-3 | 3 | |
| Q8NB25-4 | 4 |
RefSeq proteins (3): NP_001093881, NP_001275505, NP_078857* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039478 | FAM184A/B_N | Domain |
Pfam: PF15665
UniProt features (18 total): sequence conflict 5, splice variant 5, sequence variant 3, coiled-coil region 3, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NB25-F1 | 74.71 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 107 (showing top):
AP1_01, GOCC_MICROTUBULE_ORGANIZING_CENTER, DAWSON_METHYLATED_IN_LYMPHOMA_TCL1, AP1_Q4_01, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4, GOCC_CENTROSOME, TGANTCA_AP1_C, NFE2_01, GOCC_RIBONUCLEOPROTEIN_GRANULE, GOCC_CILIUM, GOCC_CILIARY_BASAL_BODY, GOCC_CENTRIOLAR_SATELLITE, chr6q22, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): P-body (GO:0000932), obsolete extracellular space (GO:0005615), cytosol (GO:0005829), centriolar satellite (GO:0034451), ciliary basal body (GO:0036064), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| binding | 1 |
| cytoplasmic ribonucleoprotein granule | 1 |
| cytoplasm | 1 |
| centrosome | 1 |
| microtubule organizing center | 1 |
| cilium | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
481 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM184A | SHISAL1 | Q3SXP7 | 543 |
| FAM184A | OR5H1 | A6NKK0 | 432 |
| FAM184A | ZNF155 | Q12901 | 403 |
| FAM184A | PRR20A | P86496 | 400 |
| FAM184A | ZNF688 | P0C7X2 | 372 |
| FAM184A | PHGR1 | C9JFL3 | 358 |
| FAM184A | FAM124A | Q86V42 | 348 |
| FAM184A | CAMTA2 | O94983 | 348 |
| FAM184A | SPDYC | Q5MJ68 | 348 |
| FAM184A | ERICH6 | Q7L0X2 | 336 |
| FAM184A | HECTD2 | Q5U5R9 | 336 |
| FAM184A | SEC14L5 | O43304 | 324 |
| FAM184A | CCDC178 | Q5BJE1 | 324 |
| FAM184A | FHIP2A | Q5W0V3 | 324 |
| FAM184A | FAM167B | Q9BTA0 | 323 |
IntAct
37 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM184A | PPP1R13B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM184A | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM184A | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM184A | HRAS | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM184A | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDR2 | IGSF3 | psi-mi:“MI:0914”(association) | 0.530 |
| FAM184A | LRRK2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM184A | KTN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FAM184A | SMARCA2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| BRAP | FAM184A | psi-mi:“MI:0915”(physical association) | 0.370 |
| FAM184A | psi-mi:“MI:0915”(physical association) | 0.370 | |
| PYCARD | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL4B | APBB1 | psi-mi:“MI:0914”(association) | 0.350 |
| RYBP | PIPSL | psi-mi:“MI:0914”(association) | 0.350 |
| RYBP | FAM186A | psi-mi:“MI:0914”(association) | 0.350 |
| WHAMMP3 | EXOC5 | psi-mi:“MI:0914”(association) | 0.350 |
| BORCS6 | UQCRQ | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC61 | INPPL1 | psi-mi:“MI:0914”(association) | 0.350 |
| PLEKHO2 | MAP3K6 | psi-mi:“MI:0914”(association) | 0.350 |
| DNAJC27 | METAP2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (90): FAM184A (Two-hybrid), FAM184A (Two-hybrid), FAM184A (Two-hybrid), BRCA1 (Two-hybrid), FAM184A (Affinity Capture-MS), FAM184A (Biochemical Activity), FAM184A (Affinity Capture-MS), FAM184A (Two-hybrid), FAM184A (Affinity Capture-MS), FAM184A (Affinity Capture-MS), FAM184A (Reconstituted Complex), FAM184A (Reconstituted Complex), FAM184A (Protein-RNA), FAM184A (Proximity Label-MS), FAM184A (Proximity Label-MS)
ESM2 similar proteins: D3ZZL9, E9Q1U1, F4I9A2, O75330, O97961, P49454, P61430, P97779, Q00547, Q03410, Q0VBY1, Q13439, Q14789, Q15075, Q15643, Q28628, Q4R7H3, Q53EZ4, Q5M7B7, Q5RI56, Q5T9S5, Q60563, Q61595, Q62209, Q640L5, Q6TFL3, Q70FJ1, Q7FAD5, Q861Q8, Q86UP2, Q8BL66, Q8CDI7, Q8CHG3, Q8HYY4, Q8IWJ2, Q8NB25, Q8NCX0, Q8R5M4, Q90631, Q90Z16
Diamond homologs: Q0KK56, Q8NB25, Q9ULE4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 34 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| endocytosis | 5 | 15.9× | 6e-03 |
| chromatin remodeling | 5 | 12.2× | 6e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
176 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 149 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3978 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:118960193:A:C | acceptor_gain | 1.0000 |
| 6:118961964:C:CC | acceptor_gain | 1.0000 |
| 6:118964774:A:C | acceptor_gain | 1.0000 |
| 6:118966831:TTAC:T | donor_loss | 1.0000 |
| 6:118966833:A:AC | donor_gain | 1.0000 |
| 6:118966833:AC:A | donor_loss | 1.0000 |
| 6:118966834:C:CC | donor_gain | 1.0000 |
| 6:118966834:CA:C | donor_gain | 1.0000 |
| 6:118966834:CAA:C | donor_gain | 1.0000 |
| 6:118966834:CAAT:C | donor_gain | 1.0000 |
| 6:118966834:CAATT:C | donor_gain | 1.0000 |
| 6:118966948:CTAAT:C | acceptor_gain | 1.0000 |
| 6:118966950:AATCT:A | acceptor_loss | 1.0000 |
| 6:118966951:AT:A | acceptor_gain | 1.0000 |
| 6:118966951:ATC:A | acceptor_loss | 1.0000 |
| 6:118966952:TC:T | acceptor_loss | 1.0000 |
| 6:118966953:C:CC | acceptor_gain | 1.0000 |
| 6:118966954:T:A | acceptor_loss | 1.0000 |
| 6:118974426:A:AC | donor_gain | 1.0000 |
| 6:118974427:C:CA | donor_gain | 1.0000 |
| 6:118974427:CG:C | donor_gain | 1.0000 |
| 6:118974427:CGA:C | donor_gain | 1.0000 |
| 6:118974427:CGACA:C | donor_gain | 1.0000 |
| 6:118974449:ATTT:A | donor_gain | 1.0000 |
| 6:118974452:T:A | donor_gain | 1.0000 |
| 6:118975028:T:C | donor_gain | 1.0000 |
| 6:118975204:TTACT:T | acceptor_gain | 1.0000 |
| 6:118975205:TACT:T | acceptor_gain | 1.0000 |
| 6:118975207:CT:C | acceptor_gain | 1.0000 |
| 6:118975207:CTCTG:C | acceptor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000004854 (6:119082878 G>A), RS1000008361 (6:119011383 T>C), RS1000008554 (6:119076742 A>C,G), RS1000008574 (6:118990531 C>A), RS1000009042 (6:119054326 A>T), RS1000059564 (6:119077021 T>C), RS1000071432 (6:118989370 T>A,C), RS1000079260 (6:118989774 G>A), RS1000103991 (6:119032512 G>A), RS1000133645 (6:119144206 C>G,T), RS1000139530 (6:119102304 C>G), RS1000155585 (6:119101278 G>T), RS1000161431 (6:118970162 C>T), RS1000174576 (6:119034110 T>A), RS1000209576 (6:118962048 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004735_32 | Epstein-Barr virus copy number in lymphoblastoid cell lines | 7.000000e-06 |
| GCST007201_67 | Schizophrenia | 2.000000e-07 |
| GCST009391_2079 | Metabolite levels | 8.000000e-06 |
| GCST009391_93 | Metabolite levels | 1.000000e-06 |
| GCST009391_980 | Metabolite levels | 5.000000e-06 |
| GCST010796_2714 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
| GCST010796_2715 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-08 |
| GCST010796_2716 | Electrocardiogram morphology (amplitude at temporal datapoints) | 9.000000e-09 |
| GCST011038_6 | Parkinson’s disease progression (motor) | 5.000000e-06 |
| GCST011039_4 | Parkinson’s disease progression (composite) | 3.000000e-06 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010372 | phosphatidylcholine 32:0 measurement |
| EFO:0010473 | cyclic adenosine monophosphate measurement |
| EFO:0010538 | taurocholate measurement |
| EFO:0004327 | electrocardiography |
| EFO:0008336 | disease progression measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 8 |
| Benzo(a)pyrene | affects methylation, decreases expression, increases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| trichostatin A | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| pentanal | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Aldehydes | increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Cisplatin | increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases expression, decreases methylation | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Epstein-Barr virus infection